These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI). Arevalo-Rodriguez I; Smailagic N; Roqué I Figuls M; Ciapponi A; Sanchez-Perez E; Giannakou A; Pedraza OL; Bonfill Cosp X; Cullum S Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010783. PubMed ID: 25740785 [TBL] [Abstract][Full Text] [Related]
23. Sex differences in cognitive function trajectories and their determinants in older adults: Evidence from the Chinese longitudinal healthy longevity survey. Tu L; Lv X; Yuan C; Chen H; Yu X; Wang H; Zhang Q Int J Geriatr Psychiatry; 2024 Mar; 39(3):e6072. PubMed ID: 38488836 [TBL] [Abstract][Full Text] [Related]
24. Longitudinal Maintenance of Cognitive Health in Centenarians in the 100-plus Study. Beker N; Sikkes SAM; Hulsman M; Tesi N; van der Lee SJ; Scheltens P; Holstege H JAMA Netw Open; 2020 Feb; 3(2):e200094. PubMed ID: 32101309 [TBL] [Abstract][Full Text] [Related]
25. Dementia subtypes, cognitive decline and survival among older adults attending a memory clinic in Cape Town, South Africa: a retrospective study. Ssonko M; Hardy A; Naganathan V; Kalula S; Combrinck M BMC Geriatr; 2023 Dec; 23(1):829. PubMed ID: 38071284 [TBL] [Abstract][Full Text] [Related]
26. Association Between Neuropsychiatric Symptom Trajectory and Conversion to Alzheimer Disease. Lo TWB; Karameh WK; Barfett JJ; Fornazzari LR; Munoz DG; Schweizer TA; Fischer CE; Alzheimer Dis Assoc Disord; 2020; 34(2):141-147. PubMed ID: 31633557 [TBL] [Abstract][Full Text] [Related]
27. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease. Giorgio J; Landau SM; Jagust WJ; Tino P; Kourtzi Z; Neuroimage Clin; 2020; 26():102199. PubMed ID: 32106025 [TBL] [Abstract][Full Text] [Related]
29. Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations. Eikelboom WS; van den Berg E; Singleton EH; Baart SJ; Coesmans M; Leeuwis AE; Teunissen CE; van Berckel BNM; Pijnenburg YAL; Scheltens P; van der Flier WM; Ossenkoppele R; Papma JM Neurology; 2021 Sep; 97(13):e1276-e1287. PubMed ID: 34413181 [TBL] [Abstract][Full Text] [Related]
30. Multi-modal latent factor exploration of atrophy, cognitive and tau heterogeneity in Alzheimer's disease. Sun N; Mormino EC; Chen J; Sabuncu MR; Yeo BTT; Neuroimage; 2019 Nov; 201():116043. PubMed ID: 31344486 [TBL] [Abstract][Full Text] [Related]
31. Study partner-reported decline identifies cognitive decline and dementia risk. Nosheny RL; Jin C; Neuhaus J; Insel PS; Mackin RS; Weiner MW; Ann Clin Transl Neurol; 2019 Dec; 6(12):2448-2459. PubMed ID: 31721455 [TBL] [Abstract][Full Text] [Related]
32. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease. Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S; Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118 [TBL] [Abstract][Full Text] [Related]